We have helped 100+ companies launch


We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional startup or early stage companies.

85+

angel investors

$
50m+

funded

115

portfolio companies

Present your Company

The DESERT ANGELS ™ welcomes applications from startup or early stage companies. We evaluate applications on an ongoing basis and meet monthly from September through June.

Present your company
Created with Sketch.

Become a member

As a vibrant, growing organization, the DESERT ANGELS ™ welcomes new members. If you are an accredited investor with a tenacious appetite for helping early-stage companies succeed, we’d love to get to know you better at an upcoming dinner meeting.

Join now
Created with Sketch.
January 22, 2018

It is safe to say that there would have been no Calimmune without the early support of the Desert Angels.

Many members of the DA share our passion and see the potential for gene therapy to transform healthcare and liberate patients from chronic and incurable diseases. Their investments have helped us grow this company to what it is today. We truly hope Calimmune’s work will be life-changing for the people we plan to serve and the investors that supported us.

LOUIS BRETON - CEO | CALIMMUNE
Calimmune has assembled a world-class team of researchers, clinicians and translational experts in related fields of science and medicine to develop innovative cell-based therapies for HIV.

Latest News and Updates

Paradigm Diagnostics, a leading precision medicine company focused on comprehensive cancer testing, announced the addition of Mara Aspinall, Managing Director of BlueStone Venture Partners to the Board of Directors as part of the closing of Paradigm’s $15 million Series B fundraising. In addition to participation by the founding investors, Mesa Verde Venture Partners, New Science Ventures, […]

Keep reading

Over its 30-year history, the U.S. Space Shuttle fleet flew 135 times and cost an estimated $209 billion. That works out to about one launch every three months, at a cost of $1.55 billion per launch — a far cry from NASA’s original goal of launching once per week, at a cost of $20 million per launch. But […]

Keep reading

On April 30, 2019, HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its IVD Test Developmentand Component Supply Agreement with Illumina, Inc. (Illumina), previously amended in June 2017, to enable the expansion of potential fields for development and commercialization of IVD test kits for use with […]

Keep reading